Medicamentos exclusivos con principios activos erenumab, fremanezumab y galcanezumab de varios laboratorios farmacéuticos

Deadline:N/A

Tender information
Murcia
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
CS/9999/1101206684/26/EXCL
Medicamentos exclusivos con principios activos erenumab, fremanezumab y galcanezumab de varios laboratorios farmacéuticos

Erenumab 140mg 1 pluma precargada 1ml solucion inyectable

Erenumab 140mg 1 pluma precargada 1ml solucion inyectable

Erenumab 70mg 1 pluma precargada 1ml solucion inyectable

Erenumab 70mg 1 pluma precargada 1ml solucion inyectable

Fremanezumab 225mg 1 jeringa precargada 1,5ml solucion inyectable

Fremanezumab 225mg 1 jeringa precargada 1,5ml solucion inyectable

Fremanezumab 225mg 1 pluma precargada 1,5ml solucion inyectable

Fremanezumab 225mg 1 pluma precargada 1,5ml solucion inyectable

Galcanezumab 120mg 1 pluma precargada 1 ml solucion inyectable

Galcanezumab 120mg 1 pluma precargada 1 ml solucion inyectable

Buyer
Servicio Murciano de Salud - Junta de Compras
buyer-email@mail.com
organization number
Contract award
tenderer iconORGANON SALUD, S.L.tenderer status icon trophyAwarded
tenderer iconTEVA PHARMA, S.L.U.tenderer status icon trophyAwarded
tenderer iconNOVARTIS FARMACÉUTICA, S.Atenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf1 Jan 1970, 00:001 Bytes
Second document.pdf1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
17 Sept - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?